Samba, Sindhu N.
Daklallah, Youssef
Brown, Sydney E. S.
Colquhoun, Douglas A.
Modi, Zubin J.
Nause-Osthoff, Rebecca
Article History
Received: 16 February 2024
Accepted: 28 May 2024
First Online: 10 June 2024
Declarations
:
: This case series study was reviewed and approved by the Institutional Review Board (IRB) with written consent waived (University of Michigan HUM00216728).
: Not applicable.
: Dr. Douglas Colquhoun declares past research support from Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., (Rahway, New Jersey) and current research support from Chiesi USA, Inc (Cary, NC) paid to the University of Michigan unrelated to presented work. Dr Colquhoun reports receiving an honorarium from Medscape, Inc unrelated to presented work.